- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
4 Pharma Firms Lose Licenses Over Pregabalin, Tapentadol Misuse

Jammu: Cracking down on the illegal sale of habit-forming pharmaceutical drugs, the Jammu and Kashmir Drugs Control Department has cancelled the licenses of four pharmaceutical firms for their alleged involvement in "clandestine purchase and sale" of addictive medicines, a government official said on Saturday.
According to an official spokesperson, State Drugs Controller-cum-Licensing Authority Lotika Khajuria ordered stringent enforcement action against the following wholesale firms: Healthways Pharma, Rajouri; Nuegene Pharmaceutical Distributors; N T Traders, Baramulla and Essence Pharmaceutical Distributors, Srinagar.
The action followed detailed inspections conducted at the premises of these firms, the spokesperson told PTI.
During these inspections, the authorities discovered that the establishments were allegedly engaged in the “clandestine purchase and sale of habit-forming pharmaceutical preparations, mainly Tapentadol and Pregabalin”. These drugs were being procured from neighboring states without adherence to mandatory regulatory requirements such as maintaining proper sale and purchase records, the official added.
The spokesperson noted that the move demonstrates the department’s commitment to ensuring public health and curbing pharmaceutical misuse. “The action against the firms reflects the department’s commitment to public health and safety and its firm resolve to prevent drug misuse, especially among vulnerable populations,” the official said.
He further warned that “any act that contributes to drug misuse or circumvents the law will be met with the strongest possible action.”
Citizens have been urged to remain vigilant and report any unethical practices involving the sale or misuse of prescription drugs to the department's dedicated helpline.
Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751